title: Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension.
authors.forename: L C
authors.initials: LC
authors.lastname: Rump
authors.forename: E
authors.initials: E
authors.lastname: Ambrosioni
authors.forename: M
authors.initials: M
authors.lastname: Burnier
authors.forename: W
authors.initials: W
authors.lastname: Hörl
authors.forename: A J
authors.initials: AJ
authors.lastname: Rabelink
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000068557:Olmesartan Medoxomil; D012720:Severity of Illness Index; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D004232:Diuretics; D007093:Imidazoles; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D000068557:Olmesartan Medoxomil